Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
Adipotide
Weight Management
AOD-9604
Weight Management
BPC-157
Healing & Recovery
Cagrilintide
Weight Management
CJC-1295
Growth Hormone
DSIP
Sleep & Recovery
Epithalon
Anti-Aging
GHK-Cu
Anti-Aging
GHRP-2
Growth Hormone
HCG
Hormone Support
Hexarelin
Growth Hormone
HGH
Growth Hormone
IGF-1 LR3
Growth Hormone
Kisspeptin
Hormone Support
Melanotan-2
Cosmetic
MOTS-C
Metabolic
NAD+
Anti-Aging
Oxytocin Acetate
Hormone Support
PEG-MGF
Recovery
PNC-27
Cancer Research
PT-141
Sexual Health
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Snap-8
Cosmetic
SS-31
Mitochondrial
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Thymosin Alpha-1
Immune
Tirzepatide
Weight Management
Total Peptides: 32
Back to Home

Peptide Comparison

PinealonvsSemax

Neuroprotective tripeptide bioregulator (Glu-Asp-Arg) that penetrates the DNA major groove to epigenetically regulate serotonin synthesis, preserve dendritic spine architecture, and activate endogenous antioxidant defenses against age-related neurodegeneration

A brain-boosting peptide that supercharges your cognitive function by ramping up BDNF—the protein your neurons need to grow, connect, and stay sharp—all delivered through a simple nasal spray.

CognitiveCognitive

At a Glance

Quick
comparison

Dose Range

Pinealon

10–20 mg

Semax

200–900 mcg

Frequency

Pinealon

Multiple times daily

Semax

Once daily

Administration

Pinealon

Oral (capsule/tablet)

Semax

Intranasal spray

Cycle Length

Pinealon

2-4 weeks

Semax

4-6 weeks

Onset Speed

Pinealon

Gradual (3-4 weeks)

Semax

Rapid (hours to days)

Evidence Level

Pinealon

Emerging preclinical

Semax

Moderate human trials (Phase 1-2)

Efficacy

Benefit
ratings

Pinealon
Semax

Recovery

Pinealon88%
Semax0%

Anti-aging

Pinealon82%
Semax0%

Cognitive

Pinealon78%
Semax0%

Cognitive Enhancement

Pinealon0%
Semax94%

Neuroprotection

Pinealon0%
Semax91%

Mental Energy

Pinealon0%
Semax87%

Technical Data

Compound
specifications

Pinealon

Molecular Formula

C15H26N6O8

Molecular Weight

418.4 g/mol

Half-Life

Short plasma half-life typical of tripeptides (minutes to low hours); biological effects persist for weeks to months through epigenetic gene regulation mechanisms

Bioavailability

Orally bioavailable as a dipeptide/tripeptide absorbed by intestinal peptide transporters (PepT1/SLC15A1); crosses the blood-brain barrier; rapid cellular uptake due to ultra-short peptide structure

CAS Number

175175-23-2

Semax

Molecular Formula

C37H51N9O10S

Molecular Weight

813.9 g/mol

Half-Life

Several minutes to hours (intranasal effects persist longer)

Bioavailability

High via intranasal route (directly reaches brain)

CAS Number

80714-61-0

Protocols

Dosing
tiers

Pinealon

starting

10 mg once daily

Once daily, morning

10-14 days initial assessment

Begin with the standard Khavinson bioregulator starting protocol. Take orally with water before breakfast. As an ultrashort peptide, Pinealon is absorbed intact by intestinal peptide transporters. Monitor for any initial sedation from serotonergic effects and adjust timing if needed. Effects are gradual and cumulative — do not expect immediate changes.

standard

10-20 mg daily (1-2 capsules)

1-2 times daily (morning, and optionally early afternoon)

20-30 days per treatment course

Standard clinical protocol used in Russian bioregulator therapy. Courses are typically 20-30 days with intervals of 3-6 months between courses. Can be combined with other Khavinson bioregulators (Epithalon, Cerluten) for comprehensive anti-aging protocols. The epigenetic effects persist beyond the active treatment period as gene expression patterns are modified.

advanced

20 mg daily (2 capsules)

Twice daily (10 mg morning + 10 mg afternoon)

30 days per course

Upper range protocol for individuals with established tolerance or greater age-related decline. Often combined with complementary bioregulators: Epithalon for pineal melatonin support, Cerluten for broader CNS peptide complex effects, and Cortexin for neurotrophic factor support. Maintain 3-6 month intervals between courses. Extended use data from 30+ years of Khavinson bioregulator clinical experience supports long-term safety.

Semax

starting

200-300 mcg

Once daily

1-2 weeks

Start low to assess your tolerance and response. The 0.1% nasal solution delivers about 50-100 mcg per drop—typically 2-3 drops per nostril. Most people notice effects within the first few days.

standard

300-600 mcg

Once or twice daily

3-4 weeks

The most commonly used range for cognitive enhancement. Russian clinical protocols typically use 200-600 mcg per day. Take in the morning to avoid sleep interference. Can split into morning and early afternoon doses.

advanced

600-900 mcg

Once or twice daily

4-6 weeks

Higher doses used in clinical settings for stroke recovery and brain injury. The 1% solution (stronger formulation) is sometimes used here. Always work with a healthcare provider at these levels.

Applications

Best
suited for

Pinealon

Neuroprotection against age-related cognitive decline and neurodegeneration

Pinealon is particularly effective for individuals focused on neuroprotection against age-related cognitive decline and neurodegeneration. Research supports its use in this area.

Supporting serotonin production in aging individuals with diminished serotonergic function

Pinealon is particularly effective for individuals focused on supporting serotonin production in aging individuals with diminished serotonergic function. Research supports its use in this area.

Bioregulatory approach to brain aging using Khavinson peptide methodology

Pinealon is particularly effective for individuals focused on bioregulatory approach to brain aging using khavinson peptide methodology. Research supports its use in this area.

Complementing other neuroprotective peptides in comprehensive anti-aging protocols

Pinealon is particularly effective for individuals focused on complementing other neuroprotective peptides in comprehensive anti-aging protocols. Research supports its use in this area.

Semax

Students and Knowledge Workers

If your day revolves around learning, studying, or processing complex information, Semax can be a game-changer. It enhances memory consolidation and recall while improving your ability to focus for extended periods—perfect for exam prep or demanding projects.

Those Seeking Mental Clarity

Brain fog? Semax works by boosting BDNF—the protein that helps neurons communicate effectively. Users often report feeling like the 'mental static' clears away, leaving sharper, more efficient thinking in its place.

Neuroprotection Seekers

Beyond immediate cognitive benefits, Semax offers protective effects for your brain cells. It acts as an antioxidant (especially against copper toxicity) and supports neuronal health—valuable for anyone concerned about long-term brain wellness.

Recovery Support (Under Medical Supervision)

In Russia, Semax is approved for helping stroke patients and those with traumatic brain injuries recover cognitive function. While not FDA-approved for this use elsewhere, the research shows meaningful neuroprotective and neurorestorative properties.

Safety Profile

Side
effects

Pinealon

Common

  • Mild drowsiness
  • Mild headache
  • Vivid dreams
  • Mild gastrointestinal discomfort

Uncommon

  • Transient mood changes
  • Changes in sleep patterns

Serious

  • Theoretical serotonergic interaction

Semax

Common

  • Nasal irritation
  • Mild headache
  • Increased alertness

Uncommon

  • Temporary blood pressure increase
  • Dizziness

Serious

  • Allergic reaction

Research Status

Safety
& evidence

Pinealon

Evidence Level

Emerging preclinical

FDA Status

Research compound

Safety Overview

Pinealon shows excellent safety profile in Russian clinical trials with no serious adverse events at therapeutic intramuscular doses. Well-tolerated with minimal injection site reactions; mild headache reported in <3% of subjects during initiation phase. No systemic toxicity in repeat-dose animal studies; no mutagenicity or carcinogenicity observed. Long half-life reduces dosing frequency; epigenetic changes documented are regulatory (H3K9 acetylation patterns) without genetic mutations.

Contraindications

  • xKnown hypersensitivity to Pinealon or its constituent amino acids (glutamic acid, aspartic acid, arginine)
  • xPregnancy and breastfeeding — insufficient safety data in reproductive studies
  • xConcurrent use of serotonergic medications (SSRIs, MAOIs) without medical supervision — theoretical risk of additive serotonergic effects
  • xAutoimmune conditions affecting the CNS — immunomodulatory peptide effects may be unpredictable

Semax

Evidence Level

Moderate human trials (Phase 1-2)

FDA Status

Research compound

Safety Overview

Semax has been used clinically in Russia for over 25 years with an excellent safety profile. It's approved there for treating stroke, cognitive impairment, and optic nerve diseases. Studies consistently show minimal side effects, mostly limited to mild nasal irritation when using the spray form. Unlike stimulants, Semax doesn't appear to cause tolerance, dependence, or withdrawal symptoms even with extended use.

Contraindications

  • xPregnancy or planning to become pregnant
  • xCurrently breastfeeding
  • xHistory of seizures or epilepsy
  • xKnown allergy to ACTH-related peptides
  • xUncontrolled hypertension

Decision Guide

Which is
right for you?

Choose Pinealon if...

  • Neuroprotection against age-related cognitive decline and neurodegeneration
  • Supporting serotonin production in aging individuals with diminished serotonergic function
  • Bioregulatory approach to brain aging using Khavinson peptide methodology
  • Complementing other neuroprotective peptides in comprehensive anti-aging protocols

Choose Semax if...

  • Cognitive enhancement
  • Memory improvement
  • Focus and concentration
  • Neuroprotection